Seaport Therapeutics, Inc. (SPTX)
NMS · Healthcare · Biotechnology
$20.76
+5.22%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.11B
Shares Outstanding
53.5M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (16.2M) | (27.5M) |
| Net Income | (13.1M) | (25.4M) |
| Diluted EPS | $-0.34 | $-0.48 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (52.4M) | (87.3M) |
| Net Income | (46.9M) | (74.9M) |
| Diluted EPS | $-1.21 | $-1.94 |